Surgical Treatments to Control Drooling (Sialorrhea)

Number: 0265

Table Of Contents

Policy
Applicable CPT / HCPCS / ICD-10 Codes
Background
References

---

Policy

Scope of Policy

This Clinical Policy Bulletin addresses surgical treatments to control drooling (sialorrhea).

1. Medical Necessity

   Aetna considers surgical correction of refractory excessive drooling medically necessary for members who meet both of the following criteria.

   1. Members must have excessive drooling that is associated with significant morbidity such as skin maceration, poor oral hygiene or dehydration; and
   2. Members must have failed to adequately respond to appropriate physical therapy and drug therapy.

   The following surgical procedures to control excessive drooling may be considered medically necessary for members who meet the selection criteria listed above:

   1. Excision of submandibular gland, with or without parotid duct ligation
   2. Four-duct ligation (i.e., ligation of bilateral submandibular ducts and bilateral parotid ducts)
   3. Parotid duct diversion, bilateral (Wilke type procedure)
   4. Parotid duct diversion, bilateral, with excision of one submandibular gland
   5. Parotid duct diversion, bilateral, with excision of both submandibular glands
   6. Parotid duct diversion, bilateral, with ligation of both submandibular ducts
   7. Relocation of the submandibular ducts, with or without removal of sublingual glands
   8. Tympanic neurectomy or chorda tympani neurectomy.

2. Experimental and Investigational

   Aetna considers transoral submandibular ganglion neurectomy, alone or in combination with sublingual gland excision, experimental and investigational for correction of drooling because the effectiveness of this approach has not been established.

3. Cosmetic

   Aetna considers surgical correction of drooling cosmetic when criteria are not met.

4. Related Policies

   • CPB 0113 - Botulinum Toxin

---

Table:

CPT Codes / HCPCS Codes / ICD-10 Codes

Code	Code Description
Information in the [brackets] below has been added for clarification purposes.   Codes requiring a 7th character are represented by "+":
CPT codes covered if selection criteria are met:
42440	Excision of submandibular (submaxillary) gland
42507	Parotid duct diversion, bilateral (Wilke type procedure)
42509	with excision of both submandibular glands
42510	with ligation of both submandibular (Wharton's) ducts
42665	Ligation salivary duct, intraoral [four- duct ligation]
69676	Tympanic neurectomy
CPT codes not covered for indications listed in the CPB:
Transoral submandibular ganglion neurectomy - no specific code
Other CPT codes related to the CPB:
42450	Excision of sublingual gland
42500	Plastic repair of salivary duct, sialodochoplasty; primary or simple
42505	secondary or complicated
42550	Injection procedure for sialography
70390	Sialography, radiological supervision and interpretation
HCPCS codes covered if selection criteria are met:
D7981	Excision of salivary gland, by report
Other HCPCS codes related to the CPB:
D0310	Sialography
ICD-10 codes covered if selection criteria are met:
K11.1	Hypertrophy of salivary gland
K11.7	Disturbances of salivary secretion

---

Background

Excessive drooling (sialorrhea, ptyalism) is estimated to occur in 10 % of patients with cerebral palsy (CP), and in other patients with neurological damage.  While drooling can be considered a cosmetic problem, excessive drooling can result in significant hygienic problems, maceration of the skin and dehydration.  Furthermore, excessive drooling can limit any efforts at speech therapy.

Drooling can either be related to a central neurogenic problem, as in CP, in which there is poor coordination of the muscles of deglutination, or be related to a peripheral nerve lesion, such as in facial nerve or glossopharyngeal nerve palsy.  All patients should initially be treated with various physical therapy and behavior modifications regimens.  Medical therapy has focused on the use of anti-cholinergic drugs (e.g., amitriptyline, atropine, glycopyrrolate, hyoscyamine, and transdermal scopolamine), which reduce the production of saliva.  However, therapeutic doses of these drugs usually result in unacceptable side effects such as constipation, urinary retention, blurred vision and restlessness.  When conservative approaches fail, surgical intervention can be considered.

Surgical management of sialorrhea includes rerouting the parotid or submandibular ducts, excision of the submandibular glands or transection of the nerves innervating the parotid gland (tympanic neurectomy) or submandibular gland (chorda tympani neurectomy).  Although none of the procedures has been studied in large series of patients, all seem to be associated with a success rate of greater than 82 %.  Selection of the procedure seems to be largely a physician/patient preference issue, balancing the increased morbidity of the gland excision or duct relocation procedures against the threat of recurrence and the loss of taste associated with the neurectomy procedures.

Glynn and O'Dwyer (2007) stated that submandibular duct relocation plus or minus excision of the sublingual glands are relatively simple procedures with low morbidity.  In a prospective study, these researchers compared both procedures including operative time, length of hospital stay, post-operative complications, drooling scores and parental satisfaction.  A total of 71 submandibular duct relocation and 29 submandibular duct relocation plus excision of the sublingual glands procedures were performed.  Exclusion criteria were patients with recurrent aspiration pneumonias or dental caries.  Two patients were lost to follow-up and excluded from the study.  Operative time and length of hospital stay were increased in the submandibular duct relocation plus sublingual gland excision group.  Drooling scores and parental satisfaction results were excellent, 93 % of parents in the submandibular duct relocation group and 89 % of parents in the duct relocation plus sublingual glands excision were satisfied and would recommend the procedure.  There was no statistical difference (p = 0.643) in drooling scores between the 2 procedures.  Post-operative morbidity was higher with the addition of sublingual gland excision, with post-operative hemorrhage occurring in 13.7 % and 36 % of parents expressing concern over post-operative pain, compared with 3 % post-operative hemorrhage rate with submandibular duct relocation and only 12 % of parents expressing the same concerns.  The authors concluded that both procedures are effective in drooling control, but the addition of sublingual gland excision increases morbidity.  These researchers no longer excise sublingual glands with submandibular duct relocation.

Celet Ozden et al (2012) noted that drooling complicates many neurologic disorders including CP.  Surgical treatment consists mainly of ablative (excision/ligation) or physiological (diversion) methods; combined techniques have also been proposed.  These investigators have applied bilateral diversion of both submandibular and parotid ducts in 12 CP patients (age range of 7 to 15 years).  Pre-operative drooling severity was grade 4/5 in 10 cases and grade 5/5 in 2 of the cases. All patients underwent physiotherapy for a minimum of 6 months and were consulted with a dentist, otolaryngologist, and a speech therapist before surgery.  No bleeding, hematoma, or infection has been observed in any of the patients.  Two patients had early post-operative tongue edema that regressed with conservative treatment.  All patients except 1 regressed to grade 2/5 drooling by the first post-operative month.  In 1 patient who had previously been classified as grade 5/5, surgery provided limited improvement with only 1 grade of step-down.  Satisfactory results for the patients and their families could be achieved and sustained for a median 18 months (7 to 20 months) of follow-up.  The authors concluded that the quadruple duct diversion method is an effective physiological surgical method in the control of drooling in CP.

In a prospective, non-randomized interventional study, Chanu et al (2012) evaluated the improvement in drooling in children undergoing 4-duct ligation procedure for excessive drooling and studied its effect on their quality of life.  A total of 30 drooling children of both sexes aged 4 to 15 years underwent 4-duct ligation (i.e., ligation of bilateral submandibular ducts and bilateral parotid ducts).  Comparison of pre-operative and post-operative drooling scores using Thomas-Stonell and Greenberg classification was done.  Glasgow Children's Benefit Inventory Score was used to assess the improvement in the quality of life.  Success rate in terms of improvement in drooling was 93.33 %.  A complication rate of 16.67 % was found.  The mean improvement in total drooling score after 12 months was 4.43.  The paired t-test applied on pre-operative and post-operative combined drooling scores showed p < 0.001.  The mean Glasgow Children's Benefit Inventory score was 36.15.  In the post-operative period, transient swelling of cheeks, transient swelling of submandibular glands, change in the consistency of saliva, cheek abscess, collection of saliva in the cheek, and parotid duct fistula were observed.  The authors concluded that the 4-duct ligation resulted in marked improvement in drooling and significantly increased the quality of life in drooling children.  It has few complications, which can be managed effectively.

Stern et al (2002) evaluated the safety of bilateral submandibular gland excision (SGE) with parotid duct ligation (PDL) and assessed its long-term complications and effectiveness in the treatment of chronic sialorrhea in children.  A total of 93 patients with chronic sialorrhea who underwent bilateral SGE with PDL from 1988 to 1997 were included in this study.  Main outcome measures included operative and post-operative complications, length of post-operative hospitalization, post-operative drooling, care requirements, xerostomia, dental caries, and overall satisfaction.  The mean post-operative stay was 2.4 days.  There were 3 post-operative complications.  Seventy-two families were interviewed (follow-up time, 1 to 10 years): 62 (87 %) reported no further drooling or significant improvement; 7 reported the occurrence of dry mouth; and 2 reported an increase in dental caries.  The authors concluded that bilateral SGE with PDL is a safe and consistently efficient procedure for the treatment of chronic sialorrhea in children.

Noonan et al (2014) noted that sialorrhea and chronic salivary aspiration are a major problem in many neurologically impaired children causing embarrassment, skin issues and recurrent lower respiratory tract infections (LRTI).  These researchers evaluated the effectiveness of salivary gland surgery in the treatment of chronic salivary aspiration in such children.  They compared admission rates for LRTI per annum before and after surgical intervention.  These investigators performed a retrospective review of all patients who underwent salivary management surgery for chronic aspiration under Princess Margaret Hospital's (PMH) Otolaryngology department from 2006 until 2013.  A total of 12 patients were included in this review.  Their ages ranged from 3 to 21 years (mean of 11.4).  Their genders were equally distributed.  Two patients had underlying congenital disorders; 1 had an acquired brain injury, while the majority (n = 9, 75 %) had cerebral palsy secondary to a sustained perinatal injury.  Most patients (n = 11, 91.7 %) had bilateral SGE and PDL as a primary procedure.  One patient had a laryngo-tracheal separation.  Two patients went on to have a second procedure.  The mean follow-up time was 5 years.  Using Wilcoxon Signed-Rank test, these researchers showed that the median rate of admission per annum for LRTI pre-operatively was 1.0.  This was reduced to 0.5 post-operatively, which was statistically significant (p ≤ 0.05).  The authors hypothesized that the combination of bilateral SGE and bilateral PDL is effective in reducing admissions with aspiration pneumonia in neurologically impaired children, and therefore improves the quality of life in these patients.

Naghavi and Jalali (2010) assessed the results following submandibular duct relocation and sublingual resection for the treatment of drooling.  These researchers presented the results of the surgical protocol used between 1994 and 2007 at the Drooling Clinic of Amiralmomenin Hospital in Rasht, Iran (n = 32).  The pre-operative and post-operative levels of drooling were measured.  The parents of the patients were contacted by telephone at least 1 year after operation.  Of all the patients, 18 were males and 14 were females; and were aged 6 to 26 years.  Of 30 patients with complete patients' chart, the mean drooling score fell from 7.59 to 2.71 after surgery (p < 0.0001).  In 30 patients, results of operation were ascertained by telephone at average of 5.6 years after operation.  In 78.1 % of patients, long-term result was successful and none was considered worse after the procedure.  There were few complications, none of which had any long-term adverse effects.  Swelling of submandibular glands was frequently observed in the immediate post-operative period.  Only 1 ranula was seen as delayed complication.  The authors concluded that submandibular duct relocation with simultaneous sublingual gland excision is a safe and consistently efficient procedure for the treatment of chronic sialorrhea.

Hornibrook and Cochrane (2012) reviewed the causes of severe sialorrhea, and in particular in children in whom it can become a life-long disability.  These investigators also discussed history of medical and surgical treatments.  A major advance has been the surgical relocation of the submandibular gland ducts with removal of sublingual glands.  The results of this operation, technical considerations, and its outcomes in 16 children were presented.  There were no significant complications.  Caregivers judged the effectiveness with a median score of "75 %" improvement.  The technique has become the most logical and reliable surgical treatment for drooling, with very good control in most cases.  In contrast to "Botox", its effects are permanent.

Formeister et al (2014) stated that chronic sialorrhea is a common problem for pediatric patients with disorders that affect swallowing.  While many patients are successfully treated with medical therapies such as Robinul (glycopyrrolate) and scopolamine, a number of such children are not able to tolerate the side effects of these medications.  In these cases, surgical treatments can include botulinum toxin A (Botox) injections into the major salivary glands, sublingual or submandibular gland excision (SMGE), submandibular duct ligation, PDL, or any combination of the above procedures.  These investigators reported on the 10-year experience with the surgical management of chronic sialorrhea at 1 tertiary care institution, and compared the efficacy of open surgical procedures versus Botox injections for reduction in salivary flow.  A retrospective chart review identified 27 pediatric patients with chronic sialorrhea; 21 of whom underwent Botox injections and 15 of whom underwent surgical procedures.  Pre-operative and follow-up clinic notes were reviewed to determine the level and severity of drooling as well as the effectiveness of sialorrhea reduction, as assessed by the Teacher Drooling Scale (TDS).  A total of 42% of those receiving Botox injections reported a reduction in drooling, with the average pre- and post-Botox TDS of 4.3 and 3.9, respectively (p = 0.02 by the Wilcoxon signed rank test); 9 of the patients receiving Botox injections (43 %) required multiple injections, with an average duration of effect of 3.9 months, and 7 patients (33 %) eventually required surgery.  All of the children who underwent surgery (7 bilateral SMGE with PDL, 6 SMGE only, and 2 PDL only) experienced a reduction in drooling, with average pre- and post-operative TDS of 4.5 and 2.2, respectively.  This reduction was significant by the Wilcoxon signed rank test (p = 0.001).  The authors concluded that the 10-year experience at their institution demonstrated the safety, effectiveness and long-term control of drooling in the patients undergoing surgery for intractable sialorrhea.

Four-Duct Ligation (i.e., Ligation of Bilateral Submandibular Ducts and Bilateral Parotid Ducts)

In a case-series study, Klem and Mair (1999) examined the effectiveness of bilateral submandibular and parotid duct ligation on children with severe neuromuscular impairment and chronic aspiration of salivary secretions and identified any predictable anatomical connections between the submandibular duct and sublingual glands.  A total of 5 children with severe neuromuscular impairment and recurrent aspiration pneumonitis were included in this study.  Subjects underwent bilateral submandibular and parotid duct ligation.  The oral cavities of 8 cadavers were dissected to identify anatomical connections between the submandibular duct and sublingual glands.  Main outcome measures were incidence of post-operative aspiration pneumonitis; gross anatomical connections between the submandibular duct and sublingual gland in cadaveric specimens.  No post-operative airway obstruction, infection, or xerostomia was noted, and technetium scanning confirmed control of salivary secretions from major salivary glands.  Caregivers noted diminished salivary secretions and no aspiration pneumonia.  The authors concluded that this new, simple intra-oral procedure controlled aspiration pneumonitis with minimal surgical dissection and had less morbidity than procedures involving major salivary gland excision.  Ranula formation, a common complication of submandibular duct transposition, is unlikely in this procedure because the sublingual ducts are not interrupted.

Shirley and co-workers (2003) compared results in their first 21 patients undergoing four-duct (4-duct) ligation (i.e., ligation of bilateral submandibular ducts and bilateral parotid ducts) with results reported in the literature for other procedures to treat sialorrhea.  These investigators retrospectively reviewed medical records of all 21 children who were treated with 4-duct ligation, a relatively simple intra-oral procedure to control sialorrhea, between August 1999 and September 2000 and contacted primary caregivers by telephone to answer a questionnaire regarding objective and subjective results of surgery.  Surgery was considered successful when caregivers rated patients as "much better" or "better" after surgery.  Follow-up was completed in all 21 of the patients 1 to 14 months after surgery.  The success rate of 4-duct ligation ("much better" or "better" after surgery) was 81 %, and no patient's sialorrhea problem was worse after surgery.  Major complications occurred in 2 (10 %) of the patients (1 ranula and 1 case of sialoadenitis), which were both successfully treated surgically.  Minor complications occurred in 4 (19 %) of the patients, tongue swelling that prolonged hospitalization, a ranula that resolved, and prolonged submandibular gland swelling that resolved (2 cases).  More than 50 % of patients were discharged the day of or the day after surgery.  The authors concluded that 4-duct ligation should be considered when surgery is indicated to treat sialorrhea.

In a prospective, non-randomized, interventional study, Chanu and colleagues (2012) evaluated the improvement in drooling in children undergoing 4-duct ligation procedure for excessive drooling and examined its effect on their quality of life (QOL).  The study was carried out between November 2009 and September 2011.  A total of 30 drooling children of both sexes aged 4 to 15 years underwent 4-duct ligation.  Comparison of pre-operative and post-operative drooling scores using Thomas-Stonell and Greenberg classification was performed.  Glasgow Children's Benefit Inventory Score was used to assess the improvement in the QOL.  Success rate in terms of improvement in drooling was 93.33 %.  A complication rate of 16.67 % was found.  The mean improvement in total drooling score after 12 months was 4.43.  The paired t-test applied on pre-operative and post-operative combined drooling scores showed p < 0.001.  The mean Glasgow Children's Benefit Inventory score was 36.15.  In the post-operative period, transient swelling of cheeks, transient swelling of submandibular glands, change in the consistency of saliva, cheek abscess, collection of saliva in the cheek, and parotid duct fistula were observed.  The authors concluded that 4-duct ligation resulted in marked improvement in drooling and significantly increased the QOL in drooling children.  It had few complications, which can be managed effectively.

In a consecutive series study, Khan and associates (2016) reported the clinical outcomes of the 4-duct ligation procedure in pediatric patients diagnosed as having sialorrhea and the associated complication rates and characterized patient and caregiver satisfaction.  This investigation was a retrospective cohort study at an academic tertiary pediatric center and pediatric rehabilitation hospital.  Patients included 38 children with neurological impairment who underwent a 4-duct salivary gland ligation between January 1, 2004, and July 31, 2012.  The dates of the analysis were August 2013 through February 2015.  Post-treatment assessments included duration of effect, severity and frequency of drooling before and after the procedure, patient complications, caregiver satisfaction, caregiver recommendation of the procedure, and caregiver overall assessment of the child's QOL.  Clinical and outcome measures were collected before the procedure, 1 month after the procedure, 1 year after the procedure, and at the most recent follow-up (range of 3 to 8 years).  The study cohort comprised 38 participants; their median age was 11 years (range of  5 to 17), and 37 % (14 of 38) were female.  The mean (SD) duration of effect was 52.6 (20.4) months.  Patients with previous sialorrhea management were more likely to demonstrate an improvement in their drooling frequency score at 1 year; 13 complications were documented in 12 patients.  The most common complications were persistent facial swelling and aspiration pneumonia; 80 % (28 of 35) of caregivers reported an improvement in their child's drooling at 1 month, while 69 % (25 of 36) and 71 % (24 of 34) stated that there was an improvement at the 1-year follow-up and the most recent follow-up, respectively.  The authors concluded that the 4-duct ligation procedure offered a simple, effective, and minimally invasive approach to the management of sialorrhea in children.

Endoscopic Transoral Submandibular Ganglion Neurectomy

Spock et al (2015) explored the feasibility of transoral submandibular ganglion neurectomy for the management of sialorrhea.  A total of 10 human cadaver dissections of the floor of mouth were performed bilaterally, for a total of 20 separate cases.  A transoral submandibular ganglion neurectomy was performed in 10 cadavers (20 neurectomies) easily and reliably, without injury to the submandibular duct or the main trunk of the lingual nerve.  The authors concluded that transoral submandibular ganglion neurectomy is an attractive addition to the armamentarium of surgical options for the treatment of medically intractable sialorrhea.  They stated that further study in selected patients is needed to demonstrate clinical feasibility.

Hughes and Brown (2017) carried out a retrospective review of 10 pediatric patients who underwent transoral submandibular gland excision; the series was analyzed for age, gender, indication for procedure, complications, length of hospitalization, and post-operative pathology.  Patients were followed for a minimum of 12 months.  A total of 7 females and 3 males aged 9 to 17 underwent the procedure.  Recurrent sialoadenitis, and sialolithiasis, accounted for 6 cases while salivary neoplasms (pleomorphic adenoma) accounted for 4 cases.  No patient suffered vessel or nerve injury; and no patient showed recurrent disease at 12 months follow-up.  All glands were completely removed and no patient required conversion to the transcervical approach.  The authors concluded that transoral submandibular gland excision was safe and effective in the pediatric population.  This method avoided a cervical scar, avoided injury to the marginal mandibular branch of the facial nerve, and completely removed the duct, eliminating the potentiality of remnant duct disease.  The authors have performed 10 transoral submandibular gland excisions in pediatric patients without complications.  This was a small (n = 2) retrospective study; its findings need to be validated by well-designed studies.

Ozturk and colleagues (2017) performed endoscopic transoral neurectomy of the submandibular and sublingual glands to treat drooling.  These researchers bilaterally operated 2 adult cases with treatment-resistant drooling.  In these patients, conventional treatment had failed.  Repeated botulinum toxin type A injections had been effective but were becoming less so.  The patients benefited from surgery in that their saliva scores decreased.  No issue emerged over 6 months of follow-up.  The authors concluded that endoscopic transoral neurectomy of the submandibular and sublingual glands reduced saliva production and allowed management of drooling in treatment-resistant patients.  This was a small case-series study (n = 2); its findings need to be validated by well-designed studies.

Wang and colleagues (2021) examined the effectiveness of ablating post-ganglionic parasympathetic fibers of the submandibular ganglion in combination with sublingual gland excision in the treatment of primary sialorrhea.  Healthy volunteers were initially chosen to determine a basic saliva flow rate value by saliva collection.  Next, unstimulated and stimulated saliva flow rates, and a visual analog scale (VAS) index for sialorrhea were recorded in all the patients pre- and post-operatively.  Furthermore, the generalized anxiety disorder scale was used to evaluate pre-operative anxiety symptoms.  The follow-up durations ranged from 24 to 36 months following surgery.  A total of 10 patients were included in this study.  Pre-operatively, the mean unstimulated saliva flow rate for the 10 patients was 11.26 ± 4.19 ml/10 mins, the stimulated saliva flow rate was 16.76 ± 3.49 ml/6 mins, and the VAS index was 66.29 ± 14.86.  Post-operatively, the mean unstimulated and stimulated saliva flow rates were significantly reduced to 5.99 ± 1.33 ml/10 mins (p = 0.001) and 13.28 ± 1.86 ml/6 mins (p = 0.013), respectively, and the VAS index was 25.41 ± 5.6 (p < 0.001).  No complications were observed following the operation.  The authors concluded that the findings of this study showed that ablation of post-ganglionic parasympathetic fibers of the submandibular ganglion in combination with sublingual gland excision by an intra-oral approach was a simple, safe, and efficient approach for treating primary sialorrhea.  This was a small (n = 10) study; these preliminary findings need to be validated by well-designed studies.

Concurrent Submandibular Gland Excision with Parotid Duct Ligation or Parotid Duct Rerouting

Schild and colleagues (2021) noted that chronic sialorrhea commonly occurs in patients with neurodevelopmental disorders.  While conservative management can provide sufficient symptom control, surgical intervention is often needed.  One of the most common procedures used is SMGE, with or without parotid duct ligation (PDL) or parotid duct rerouting PDR).  In a systematic review, these researchers compared these surgical approaches and their outcomes; data sources included PubMed, Web of Science, and Embase.  This systematic review included studies of patients with chronic sialorrhea treated with SMGE alone or SMGE plus PDR or PDL and reports on post-intervention outcomes and complications.  Two independent investigators evaluated study eligibility, rated quality, and extracted data for analysis.  A random effects model was used for meta-analysis of pooled data.  Of 3,186 studies identified, 21 met inclusion criteria, with 708 patients: 103 underwent SMGE alone (15 %); 299 (42 %), SMGE and PDL; and 306 (43 %), SMGE plus PDR.  Overall, a majority of patients had significant improvement, with very good-to-excellent control of symptoms after surgery: SMGE, 82 % (95 % CI: 73 % to 89 %); SMGE and PDL, 79 % (95 % CI: 73 % to 85 %); and SMGE and PDR, 85 % (95 % CI: 75 % to 92 %).  More importantly, there was no significant difference in outcomes with the addition of PDL or PDR.  Reported complications included sialocele, parotitis, dental caries, and dry mouth.  The authors concluded that this systematic review identified consistent positive outcomes with SMGE for patients with chronic sialorrhea but no additional benefit when PDR or PDL was carried out as a concurrent procedure.

Long-Term Effects of Submandibular Gland Excision on Drooling

Delsing et al (2023) noted that SGE is suitable for the treatment of drooling in patients with non-progressive neuro-disabilities.  In a cross-sectional study, these investigators examined the long-term effects of SGE in children with neurodevelopmental disorders.  Patients who had SGE between 2007 and 2018 were included.  Main outcomes were VAS, drooling severity (DS), as well as drooling frequency (DF) collected at baseline, 8 weeks, 32 weeks and with a median of 313 weeks following SGE (long-term).  Secondary outcomes were satisfaction with the procedure, drooling quotient (DQ) and adverse events (AEs).  This trial included 35 patients in the long-term analysis with a mean age of 14.5 years.  A baseline VAS score of 80.4 was found, which improved on the long-term (mean difference [MD] of -21.8, t(26) = 4.636, p < 0.0005)).  DS and DF decreased significantly at the long-term compared to baseline (Z = -4.361, p < 0.0001 for DS, Z = -3.065, p = 0.002 for DF); 23 out of 35 (66 %) patients would recommend the procedure to peers.  The authors concluded that this study indicated a long-term stable effect on drooling following SGE in patients with anterior drooling.  Recurrence of drooling occurred due to unknown reasons, nevertheless most caregivers and/or patients were still satisfied and would recommend the procedure to others.

---

References